Configured for stable performance in synthesis settings, this HPLC column NUCLEOSHELL ® RP 18 arrives in a package containing an analytical separation column, instruction leaflet, and certificate of analysis. Featuring a particle size of 5 μm and a column volume of 0.15 ml, it employs a reversed phase (RP) separation principle using high density monomeric octadecyl (C 18 , ODS) modification, base deactivated (BDS). With a specific surface area of 90 m²/g, it offers hydrophobic (van der Waals) interactions and retention mechanisms, making it ideal for separating antibiotics, antidepressants, anti-inflammatory drugs, herbicides, immunosuppressants, phytopharmaceuticals, and suitable for LC-MS applications. Its

• Category: Separation columns for HPLC
• Pressure stability: 600 bar
• Column shape: Analytical separation column
• Particle type: Core-shell, superficially porous particles (SPP)
• Separation principle: Reversed phase (RP)
• Pore size: 90 Å
• Interactions / retention mechanism: hydrophobic (van der Waals)
• Particle size: 5 µm
• L x Ø internal (column): 50 x 2 mm
• Column type: HPLC column
• Pore volume: 0.9 ml/g
• Phase: RP 18
• Recommended application(s): Antibiotics Antidepressants Anti-inflammatory drugs Herbicides Immunosuppressants Phytopharmaceuticals Suitable for LC-MS
• Endcapped: yes
• Eluent in column: Acetonitrile - Water
• Surface chemistry: High density monomeric octadecyl (C 18 , ODS) modification, Base deactivated (BDS)
• Temperature stability: 60 ° C
• Specific surface according to BET: 90 m²/g
• USP listing: L1
• Column volume: 0.15 ml
• pH stability: 1,0-11,0